Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Vaccinogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011814
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vaccinogen Inc (Vaccinogen) is an immunotherapy company that develops products for the treatment of solid tumors. The company provides oncovax products. It provides immunotherapy products to treat solid tumors and commercializes autologous tumor vaccine products. Vaccinogen’s products are used in the treatment of cancer, infectious disease, autoimmune and anti-inflammatory diseases. The company also discovers, develops and manufactures fully human monoclonal antibodies for human clinical use. It conducts research and development on oncovax for potential uses against other solid tumors, and others. Vaccinogen is headquartered in Baltimore, Maryland, the US.

Vaccinogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vaccinogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vaccinogen Raises USD0.6 Million in Financing Round 10
Vaccinogen Raises US$6.6 Million In Venture Financing 11
Vaccinogen Raises USD2 Million in Financing Round 12
Equity Offering 13
Vaccinogen Raises USD10 Million in Second Tranche of Private Placement of Units 13
Vaccinogen Inc – Key Competitors 14
Vaccinogen Inc – Key Employees 15
Vaccinogen Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Vaccinogen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vaccinogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vaccinogen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Vaccinogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Vaccinogen Raises USD0.6 Million in Financing Round 10
Vaccinogen Raises US$6.6 Million In Venture Financing 11
Vaccinogen Raises USD2 Million in Financing Round 12
Vaccinogen Raises USD10 Million in Second Tranche of Private Placement of Units 13
Vaccinogen Inc, Key Competitors 14
Vaccinogen Inc, Key Employees 15

★海外企業調査レポート[Vaccinogen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Statnett SF-エネルギー分野:企業M&A・提携分析
    Summary Statnett SF (Statnett) transmits and distributes high voltage electricity in Norway primarily generated from its hydro-electric power plants. It operates as a system operator in the Norwegian energy system. The company is a state enterprise, established under the Act relating to state-owned …
  • Tata Steel Europe Ltd:企業の戦略・SWOT・財務情報
    Tata Steel Europe Ltd - Strategy, SWOT and Corporate Finance Report Summary Tata Steel Europe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務情報
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Western & Southern Financial Group, Inc.:企業の戦略・SWOT・財務情報
    Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Western & Southern Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • China Longyuan Power Group Corporation Ltd (916):電力:M&Aディール及び事業提携情報
    Summary China Longyuan Power Group Corporation Ltd (CLPGC), a subsidiary of China Energy Investment Corporation Ltd, carries out design, development, construction, management and operation of wind farms. It generates and sells electricity to the local grid companies. The company also operates other …
  • Alder Biopharmaceuticals Inc (ALDR):製薬・医療:M&Aディール及び事業提携情報
    Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. The company uses technologies such as the antibody selection sy …
  • Mustek Limited (MST):企業の財務・戦略的SWOT分析
    Mustek Limited (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gunvor Group Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Gunvor Group Limited (Gunvor) is a vertically integrated energy trading company. It is one of the global traders of physical crude oil; refined products and energy; and metals and bulk materials. The company provides integrated trading products and logistics service to connect upstream suppl …
  • Univalor Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Univalor Inc (Univalor) is a university technology transfer organization that optimizes research outcomes by commercializing the technological innovations of researchers from health centers and academic institutions. The organization provides researcher services such as protecting intellectu …
  • Great Eastern Holdings Limited (G07):企業の財務・戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hallmark Cards, Inc.:企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • BBB Technologies Inc:製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company, which develops devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It develops single-drop, mobile integrated diagnostic tools for blood testing. Its lead pr …
  • Telekom Malaysia Berhad:企業の戦略・SWOT・財務分析
    Telekom Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Telekom Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cellmid Ltd (CDY):製薬・医療:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Madrigal Pharmaceuticals Inc (MDGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Madrigal Pharmaceuticals Inc (Madrigal), formerly, Synta Pharmaceuticals Corp is a biopharmaceutical company focused on the development and commercialization of novel therapeutic candidates for the treatment of liver, cardiovascular and metabolic diseases. Its lead product candidate, MGL-319 …
  • PolyNovo Ltd (PNV):企業の財務・戦略的SWOT分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, designs, develops and manufactures dermal regeneration solutions for various medical applications. The company offers NovoSorb BTM (Biodegradable Temporising Matrix), a synthetic, biodegradable and biocompatible device that facilitates the growt …
  • Owensboro Municipal Utilities:企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Magellan Midstream Partners LP (MMP):企業の財務・戦略的SWOT分析
    Magellan Midstream Partners LP (MMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • International SOS Pte Ltd:企業の戦略的SWOT分析
    International SOS Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆